Adapting versatile
polymers to improve
surgical outcomes
and patient recovery

About Us

Polyganics is a medical technology company which develops, manufactures and commercializes innovative bioresorbable medical devices that facilitate natural tissue repair and regeneration after surgery.

Latest News

Oct 22, 2018

Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

read more

Sep 10, 2018

Polyganics Strengthens Global Distribution Network with Appointment of Synovis MCA as US-wide Distributor of NEUROCAP®

read more

Mar 08, 2018

FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch

read more

View all news →


Polyganics’ leadership team has a proven track record of successfully running medical technology companies. The team is highly experienced across all technical, operational and financial aspects as well as creating strategic alliances with industry partners.

Rudy Mareel

CEO (a.i.)

Romke Ribbels

Director Marketing & Business Development

Raoul Beex

International Sales Director

Bart-Jan Korteling

Director Research & Product Development